US69913P1057 - Common Stock
PARAGON 28 INC
NYSE:FNA (4/26/2024, 7:04:01 PM)
After market: 8.8 0 (0%)8.8
-0.17 (-1.9%)
Paragon 28, Inc. engages in operation of an orthopedic foot and ankle company. The company is headquartered in Englewood, Colorado and currently employs 463 full-time employees. The company went IPO on 2021-10-21. The firm develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products and product families include plates and plating systems, screws, staples, and nails to address all foot and ankle procedures, including fracture fixation, forefoot, or hallux valgus, which includes bunion and hammertoe, ankle, flatfoot, or progressive collapsing foot deformity (PCDF), Charcot foot and Ortho biologics. The company provides a comprehensive portfolio of solutions that includes surgical implants and disposables, as well as surgical instrumentation. The Company’s suite of surgical solutions comprises 75 product systems, including approximately 9,200 SKUs, which comprises of approximately 6,800 implants, 1,400 instruments and 1,000 disposable and other SKUs. Its products are available in a variety of sizes and configurations to suit the individual patient’s anatomical and surgical requirements.
PARAGON 28 INC
14445 Grasslands Drive
Englewood COLORADO
P: 17209121332
Employees: 463
Website: https://paragon28.com/
Needham says it expects growth in the orthopedic device market to slow later this year, but sees Enovis (ENOV) and Paragon 28 (FNA) as being able to beat the trend. Read more here.
Here you can normally see the latest stock twits on FNA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: